Upgrade to SI Premium - Free Trial

Galapagos NV (GLPG)

27.73 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/5/26 *Est.)

Latest Headlines

Form 6-K Lakefront Biotherapeutic For: Jun 08 June 9, 2026 6:11 AM - SEC Filing Form 6-K Lakefront Biotherapeutic For: Jun 04 June 5, 2026 6:06 AM - SEC Filing Form 6-K Lakefront Biotherapeutic For: May 26 May 27, 2026 6:04 AM - SEC Filing Form 424B3 Lakefront Biotherapeutic May 8, 2026 4:21 PM - SEC Filing Galapagos NV (GLPG) Tops Q1 EPS by 115c May 6, 2026 6:04 PM - StreetInsider Form 6-K GALAPAGOS NV For: May 06 May 6, 2026 5:19 PM - SEC Filing Form 6-K GALAPAGOS NV For: Apr 28 April 29, 2026 9:00 AM - SEC Filing Galapagos NV (GLPG) PT Lowered to $28 at RBC Capital April 7, 2026 9:02 AM - StreetInsider Galapagos enters partnership with Gilead for autoimmune drug development March 31, 2026 6:19 AM - StreetInsider Form 6-K GALAPAGOS NV For: Mar 31 March 31, 2026 6:19 AM - SEC Filing Form 6-K GALAPAGOS NV For: Mar 30 March 30, 2026 8:03 AM - SEC Filing Form 20-F GALAPAGOS NV For: Dec 31 March 26, 2026 4:03 PM - SEC Filing Form 6-K GALAPAGOS NV For: Mar 23 March 24, 2026 6:03 AM - SEC Filing Gilead to buy Ouro Medicines for up to $2.2 billion March 23, 2026 6:30 PM - StreetInsider Form 6-K GALAPAGOS NV For: Mar 17 March 17, 2026 5:27 PM - SEC Filing Full Article List